MDXHEALTH SA

■ BUSINESS: tests to diagnose prostate cancer MARKET CAP: $117M

■ HEADQUARTERS: Irvine/Belgium

■ CEO: Michael McGarrity

■ Q3 NET LOSS: $8.6M (vs. $7.6M year ago)

■ NOTABLE: says Medicare getting stricter

■ on reimbursements, cuts 2022 forecast